Metabolic disturbances such as dyslipidemia, lipodystrophy syndrome, visceral obesity, hyperlactatemia, diabetes mellitus, and hepatic steatosis have been recognized as serious complications in long-term antiretroviral-treated HIV-infected patients. The oxidative capacity of liver mitochondria plays a central role in their pathogenesis and can be analyzed using the [13C]methionine breath test. We analyzed hepatic mitochondrial function using the [13C]methionine breath test in antiretrovirally treated and untreated HIV-infected patients as well as HIV-negative controls. Patients with hepatic steatosis, hypertriglyceridemia, lipohypertrophy, and older age showed reduced methionine metabolism. Hepatic mitochondrial function is impaired in antiretroviral-treated HIV-infected patients with disturbances of lipid metabolism.
Get full access to this article
View all access options for this article.
References
1.
BonnetF, CheneG, ThiebautRet al.Trends and determinants of severe morbidity in HIV-infected patients: The ANRS CO3 Aquitaine Cohort, 2000–2004. HIV Med, 2007; 8:547–554.
2.
BauerAM, SternfeldT, HorsterSet al.Kinetics of lactate metabolism after submaximal ergometric exercise in HIV-infected patients. HIV Med, 2004; 5:371–376.
3.
KohlerJJ, LewisW. A brief overview of mechanisms of mitochondrial toxicity from NRTIs. Environ Mol Mutagen, 2007; 48:166–172.
4.
KakudaTN. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther, 2000; 22:685–708.
5.
KoletzkoB, DemmelmairH, HartlWet al.The use of stable isotope techniques for nutritional and metabolic research in paediatrics. Early Hum Dev, 1998; 53,Suppl:S77–S97.
6.
BanaschM, GoetzeO, HollbornIet al.13C-methionine breath test detects distinct hepatic mitochondrial dysfunction in HIV-infected patients with normal serum lactate. J Acquir Immune Defic Syndr, 2005; 40:149–154.
7.
MilazzoL, PiazzaM, SangalettiOet al.[13C]Methionine breath test: A novel method to detect antiretroviral drug-related mitochondrial toxicity. J Antimicrob Chemother, 2005; 55:84–89.
8.
MilazzoL, RivaA, SangalettiOet al.13C-Methionine breath test detects liver mitochondrial impairment in HIV-infected patients with antiretroviral drug-related hyperlactatemia. J Acquir Immune Defic Syndr, 2004; 35:429–432.
9.
ArmuzziA, MarcocciaS, ZoccoMAet al.Non-Invasive assessment of human hepatic mitochondrial function through the 13C-methionine breath test. Scand J Gastroenterol, 2000; 35:650–653.
10.
IshiiY, AsaiS, KohnoTet al.Evaluation of liver regeneration using the L-[1-13C]methionine breath test. J Surg Res, 2001; 95:195–199.
11.
SpahrL, NegroF, LeandroGet al.Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis. Med Sci Monit, 2003; 9:CR6–CR11.
12.
CasademontJ, SanjurjoE, GarrabouG, MiroO. Diagnosis of mitochondrial dysfunction in HIV-infected patients under highly active antiretroviral therapy: Possibilities beyond the standard procedures. Antivir Ther, 2005; 10,Suppl 2:M65–M71.
13.
SpahrL, NegroF, Rubbia-BrandtLet al.Acute valproate-associated microvesicular steatosis: Could the [13C]methionine breath test be useful to assess liver mitochondrial function?Dig Dis Sci, 2001; 46:2758–2761.
14.
CandelliM, ArmuzziA, NistaECet al.13C-Methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther, 2004; 19:243.
15.
CandelliM, CazzatoIA, ZoccoMAet al.13C-breath tests in the study of mitochondrial liver function. Eur Rev Med Pharmacol Sci, 2004; 8:23–31.
16.
MieleL, GriecoA, ArmuzziAet al.Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am J Gastroenterol, 2003; 98:2335–2336.
17.
DiCampli C, AngeliniG, ArmuzziAet al.Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation. Eur J Gastroenterol Hepatol, 2003; 15:727–732.
18.
ArmuzziA, CandelliM, ZoccoMAet al.Review article: Breath testing for human liver function assessment. Aliment Pharmacol Ther, 2002; 16:1977–1996.
19.
KinsellLW, HarperHA, BartonHC, MichaelsGD, WeissHA. Rate of disappearance from plasma of intravenously administered methionine in patients with liver damage. Science, 1947; 106:589–590.
20.
HorowitzJH, RypinsEB, HendersonJMet al.Evidence for impairment of transsulfuration pathway in cirrhosis. Gastroenterology, 1981; 81:668–675.
21.
AlbericiLC, OliveiraHC, BighettiEJet al.Hypertriglyceridemia increases mitochondrial resting respiration and susceptibility to permeability transition. J Bioenerg Biomembr, 2003; 35:451–457.
LoebLA, WallaceDC, MartinGM. The mitochondrial theory of aging and its relationship to reactive oxygen species damage and somatic mtDNA mutations. Proc Natl Acad Sci USA, 2005; 102:18769–18770.
26.
CarrA. HIV lipodystrophy: Risk factors, pathogenesis, diagnosis and management. AIDS, 2003; 17,Suppl 1:S141–S148.
27.
KangD, HamasakiN. Alterations of mitochondrial DNA in common diseases and disease states: Aging, neurodegeneration, heart failure, diabetes, and cancer. Curr Med Chem, 2005; 12:429–441.
28.
VelsorLW, KovacevicM, GoldsteinMet al.Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine. Toxicol Appl Pharmacol, 2004; 199:10–19.
